What Documentation Should a 503A Pharmacy Request?

Short answer: A 503A pharmacy should first determine, under current federal criteria, applicable state requirements and its own procedures, whether a proposed bulk drug substance may be used for the intended compounding activity, then request source and lot evidence appropriate to that decision. A product's presence in a supplier catalog is not evidence of 503A eligibility. This page is procurement education. It is not a representation that any First1BioLab product is permitted for compounding, and it is not an eligibility determination.

What to establish

Check the current federal criteria, applicable state requirements and any relevant FDA policy before procurement. A product’s presence in a supplier catalog is not evidence that it is eligible for 503A compounding. FDA urges compounders to know their bulk-substance suppliers.

What to verify

For a candidate material, request supplier/manufacturer identity, relevant registration and source information, the substance’s specification, lot-linked COA and methods, and the documents needed under the pharmacy’s own quality procedures. Verify that the COA corresponds to the actual material received.

Decision and next step

Document who reviewed eligibility and the lot evidence. Escalate identity, form and testing discrepancies before use. This guide is procurement education, not a representation that any First1BioLab product is permitted for compounding.

Practical request

Use the points above to request a defined product, sample or lot record. Ask the document issuer to explain any discrepancy; do not infer regulatory suitability from a catalog listing.

• Buyer 503a
• Quality
• Sample Coa
• Request Quote

Related guides

• 503A vs 503B Peptide API Procurement
• How to Qualify a Peptide API Supplier

Primary sources

1. FDA, Human Drug Compounding Policies and Rules
2. FDA, Know Your Bulks and Excipients Suppliers

Educational procurement guidance. Confirm the current rules for the exact material, market and intended use before purchase or use.

Your next step

Tell us what you need.

Request pricing, a sample and the relevant COA or report together. Our team replies within 24 hours.

1. Share the material, quantity and destination.
2. Receive availability, pricing, sample options and document details.
3. Confirm specifications and terms before PO / PI.

A first reply is distinct from a formal quotation; quote timing depends on a complete scope and any technical review.

Contact Us: First1biolab Pharmaceutical Technology Co., Ltd., Beijing, China.

Request a quote, sample or report

No account needed. Choose what you need in one inquiry.

What would you like?

QuotationSampleCOA / reports

Full name *Business email *Inquiry typeProduct supplyProduct sampleCOA / report requestOEM / custom projectIndependent testingBuyer typeResearch organization503A pharmacy503B facilityDistributor / resellerEU compounderOEM / brandOther professional buyerProduct / CAS / testQuantity / sample quantityDestination country / region *

Add specifications or project details (optional)

OrganizationTarget delivery dateRequired specification / formatDocuments / analytical requirements

Facility and qualification requirements

First order / annual forecast / downstream markets

Non-confidential project brief / packagingPlease arrange an NDA before confidential details are exchanged.

Sample supplier / manufacturerSample / lot referenceTesting question / selected test

Question or additional requirements

I agree to be contacted about this inquiry and have read the Inquiry Privacy Notice.Send inquiry →

Your inquiry is saved securely. Keep the reference shown after submission.

Leave blank

Documentation checklist

• Supplier and manufacturer identity
• Relevant registration and source information
• Substance specification
• Lot-linked COA, methods and results
• Documents required under the pharmacy's own quality procedures
• Confirmation that the COA corresponds to the material received

This guide is procurement education, not a representation that any First1BioLab product is permitted for compounding. It is not an eligibility determination.

Peptide COA checklist · Independent testing of a supplier sample

Frequently asked questions

Does a catalog listing mean a substance may be used in 503A compounding?

No. The page states that a product's presence in a supplier catalog is not evidence that it is eligible for 503A compounding. Check current federal criteria, applicable state requirements and relevant FDA policy before procurement.

What documents should a 503A pharmacy request from a supplier?

For a candidate material, request supplier or manufacturer identity, relevant registration and source information, the substance's specification, a lot-linked COA and methods, and the documents required under the pharmacy's own quality procedures. Verify that the COA corresponds to the material received.

Does this page determine eligibility for compounding?

No. It is procurement education. It does not determine eligibility and is not a representation that any First1BioLab product is permitted for compounding. The pharmacy remains responsible for its own review.

What if identity or testing records disagree?

Document who reviewed eligibility and the lot evidence. Escalate identity, form and testing discrepancies before use, and ask the document issuer to explain any discrepancy.